Myelodysplastic Syndrome (MDS)
Showing 26 - 50 of 77
Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS) Trial in United States
Completed
- Acute Myeloid Leukemia (AML)
- +3 more
- Selinexor
- +3 more
-
Phoenix, Arizona
- +5 more
Mar 25, 2020
Myelodysplastic Syndrome (MDS) Trial run by the NHLBI (ON 01910 Na)
Completed
- Myelodysplastic Syndrome (MDS)
- ON 01910 Na
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019
Allogeneic HCT Compared to Chemotherapy in Older AML Patients
Completed
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndrome (MDS)
-
Stanford, California
- +11 more
Nov 12, 2019
Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS) Trial in Australia, France (S 055746)
Completed
- Acute Myeloid Leukaemia (AML)
- Myelodysplastic Syndrome (MDS)
- S 055746
-
Melbourne, Australia
- +4 more
May 22, 2019
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML) Trial in Baltimore
Terminated
- Acute Myeloid Leukemia (AML)
- +2 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Apr 18, 2019
Myelodysplastic Syndrome (MDS) Trial in China (Azacitidine)
Completed
- Myelodysplastic Syndrome (MDS)
-
Beijing, China
- +10 more
Mar 4, 2019
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in New York (Laromustine (VNP40101M) and Ara-C)
Terminated
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndrome (MDS)
- Laromustine (VNP40101M) and Ara-C
-
New York, New YorkWeill Cornell Medical College
Jan 25, 2019
Myelodysplastic Syndrome (MDS) Trial in Belgium (Darbepoetin Alfa)
Completed
- Myelodysplastic Syndrome (MDS)
- Darbepoetin Alfa
-
Charleroi, Belgium
- +3 more
Oct 15, 2018
Myelodysplastic Syndrome (MDS) Trial in New York (T2* Cardiac and Liver MRI)
Completed
- Myelodysplastic Syndrome (MDS)
- T2* Cardiac and Liver MRI
-
New York, New YorkWeill Medical College of Cornell University
Oct 23, 2018
Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML) Trial in France, Germany (drug, procedure, other, genetic)
Terminated
- Myelodysplastic Syndrome (MDS)
- Acute Myeloid Leukemia (AML)
- JNJ-56022473
- +8 more
-
Nantes, France
- +9 more
Oct 23, 2018
Myelodysplastic Syndrome (MDS), Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial run by the NHLBI (Stem Cell
Completed
- Myelodysplastic Syndrome (MDS)
- +4 more
- Stem Cell Transplantation
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 3, 2018
Leukemia, Acute, Chronic Myelogenous Leukemia (CML), Myelodysplastic Syndrome (MDS) Trial in Stanford (Regulatory T-cells,
Terminated
- Leukemia, Acute
- +6 more
- Regulatory T-cells
- +6 more
-
Stanford, CaliforniaStanford University School of Medicine
Jun 1, 2018
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Pittsburgh (5-azacytidine (5-aza) maintenance therapy
Withdrawn
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndrome (MDS)
- 5-azacytidine (5-aza) maintenance therapy after transplant
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center
Mar 29, 2018
Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS) Trial in United States
Completed
- Acute Myeloid Leukemia (AML)
- +2 more
-
Indianapolis, Indiana
- +4 more
Oct 23, 2017
Myelodysplastic Syndrome (MDS) Trial (CDA-2 (Cell Differentiation Agent 2))
Unknown status
- Myelodysplastic Syndrome (MDS)
- CDA-2 (Cell Differentiation Agent 2)
- (no location specified)
Nov 4, 2017
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Memphis (Cytarabine, Intrathecal Triples, HPC-A)
Terminated
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndrome (MDS)
- Cytarabine
- +2 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 4, 2017
Myelodysplastic Syndrome (MDS) Trial in Germany (LBH589, Epoetin Alfa)
Terminated
- Myelodysplastic Syndrome (MDS)
- LBH589
- Epoetin Alfa
-
Mannheim, Baden-Württemberg, Germany
- +11 more
Aug 8, 2017
Myelodysplastic Syndrome (MDS) Trial run by the NHLBI (WT1 and PR1 Peptide Vaccine)
Completed
- Myelodysplastic Syndrome (MDS)
- WT1 and PR1 Peptide Vaccine
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome (MDS) Trial in Kansas City (Administration of
Completed
- Acute Myeloid Leukemia
- +4 more
- Administration of hyperbaric oxygen
-
Kansas City, KansasUniversity of Kansas Medical Center
May 9, 2017
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Myeloid Sarcoma Trial in Memphis (Cyclophosphamide,
Terminated
- Acute Lymphoblastic Leukemia (ALL)
- +6 more
- Cyclophosphamide
- +9 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 24, 2017
Leukemia, Acute Myelogenous (AML), Leukemia, Acute Lymphocytic (ALL), Leukemia, Chronic Myelogenous (CML) Trial run by the NCI
Completed
- Leukemia, Acute Myelogenous (AML)
- +4 more
- WT1 Peptide-Pulsed Dendritic Cells
- +7 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 1, 2017
For Donors, Related Donors Giving Peripheral Blood Stem Cells (PBSC) to a Sibling, For Recipients Trial in United States
Terminated
- For Donors
- +9 more
- CDX-301
- CDX-301 and plerixafor
-
Los Angeles, California
- +7 more
Apr 6, 2017
Chronic Kidney Disease, Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) Trial in Boston (Haploidentical Bone
Unknown status
- Chronic Kidney Disease
- +16 more
- Haploidentical Bone Marrow/Kidney
-
Boston, MassachusettsMassachusetts General Hospital
Mar 21, 2017
Myelodysplastic Syndrome (MDS), Aplastic Anaemia (AA), Myelofibrosis (MF) Trial in Singapore (Chinese herbal concoction twice a
Completed
- Myelodysplastic Syndrome (MDS)
- +3 more
- Chinese herbal concoction twice a day for 6 months
-
Singapore, SingaporeSingapore General Hospital
Feb 9, 2017